10 Important News Updates Investors Shouldn’t Miss

Page 9 of 9

1. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 106

Eli Lilly and Company (NYSE:LLY) develops and markets pharmaceuticals for diabetes, oncology, immunology, neuroscience, and other therapeutic areas worldwide.

Announced on February 10, Eli Lilly is expanding its collaboration with AdvanCell to advance targeted alpha therapies for cancer treatment. By using AdvanCell’s Pb-212 production technology and infrastructure alongside Lilly’s expertise in drug development, the partnership aims to accelerate clinical progress for innovative radiopharmaceuticals. Lilly sees this expansion as an opportunity to further explore Pb-212-based therapies and strengthen its commitment to developing new cancer treatments. Financial details of the agreement were not disclosed.

While we acknowledge the potential of Eli Lilly and Company (NYSE:LLY) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than LLY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9